| Period Ending: |
LTM
(Last Twelve Months) |
2024
(Q4)
12-31 |
2021
(Q2)
06-30 |
2020
(Q4)
12-31 |
|---|---|---|---|---|
| Report Filing | 2025-03-17 | 2025-03-17 | 2021-08-13 | 2021-03-31 |
| Revenue | 44.47 | 44.47 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 |
| Operating Expenses | -1.59 | 1.07 | -2.66 | -0.297 |
| Research & Development | 0 | 0 | 0 | 0 |
| Selling, General and Administrative | 8.67 | 8.67 | 0 | 0 |
| Other Operating Expenses | -10.26 | -7.6 | -2.66 | -0.297 |
| Operating Income | 1.59 | -1.07 | 2.66 | 0.297 |
| Net Non-Operating Interest | -13.36 | -13.37 | 0.004 | 0.001 |
| Interest Income | 0.004 | 0 | 0.004 | 0.001 |
| Interest Expense | 13.37 | 13.37 | 0 | 0 |
| Equity & Other Income/(Expense) | -13.49 | -6.56 | -6.94 | -0.594 |
| Income Before Tax | -25.26 | -20.99 | -4.27 | -0.296 |
| Income Tax Expense | 35.49 | 35.49 | 0 | 0 |
| Income Attributable to Non-Controlling Interest | 4.99 | 4.99 | 0 | 0 |
| Net Income | -65.74 | -61.47 | -4.27 | -0.296 |
| Depreciation and Amortization | 11.54 | 18.47 | -6.93 | -0.592 |
| EBITDA | 13.13 | 17.4 | -4.27 | -0.296 |
| Earnings Per Share (EPS) | -0.48 | -0.38 | -0.1 | -0.007 |
| Diluted Earnings Per Share | -0.48 | -0.38 | -0.1 | -0.007 |
| Weighted Average Shares Outstanding | 159,997 | 159,997 | 42.26 | 42.26 |
| Diluted Weighted Average Shares Outstanding | 159,997 | 159,997 | 42.26 | 42.26 |
